Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 2002 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.670 | None | 1.000 | 2 | 1 | 2006 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.700 | None | 0.953 | 9 | 7 | 1998 | 2020 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.200 | None | 1.000 | 1 | 2 | 2008 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2004 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.190 | None | 1.000 | 1 | 2 | 1997 | 2018 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
disease | 0.140 | None | 0.800 | 1 | 1 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.200 | None | 0.933 | 1 | 1 | 2007 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 7 | 0.419 | 0.808 | 1.00 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2018 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.150 | None | 1.000 | 2 | 2 | 1989 | 2019 | |||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.130 | None | 0.833 | 3 | 3 | 2012 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.140 | None | 0.800 | 1 | 1 | 2008 | 2018 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.460 | None | 1.000 | 4 | 3 | 2007 | 2019 | ||||||||
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
disease | 0.120 | None | 1.000 | 2 | 2 | 2014 | 2017 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.400 | None | 1.000 | 2 | 2 | 2018 | 2019 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.700 | None | 0.978 | 1 | 1 | 1983 | 2020 | ||||||||
|
forkhead box P1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
disease | 1.000 | None | 0.942 | 8 | 5 | 1992 | 2019 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.120 | None | 1.000 | 1 | 3 | 2014 | 2019 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2018 | 2019 | ||||||||
|
glucagon like peptide 1 receptor | 0.471 | 0.846 | 0.29 |
|
disease | 0.500 | None | 0.978 | 1 | 1 | 1993 | 2020 | ||||||||
|
NADPH oxidase 4 | 0.471 | 0.885 | 5.8E-20 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2018 | 2019 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.800 | None | 0.978 | 8 | 5 | 1998 | 2019 |